In the context of cancer, the activation of IGF-1R signaling has been demonstrated to initiate the expression of stemness in breast cancer (Motallebnezhad et al., 2016) and hepatocellular carcinomas (HCC) (Chang et al., 2015, 2016). Here, IGF1R is linked to breast cancer.